To unlock this feature and to subscribe to our weekly evidence emails, please create a FREE orthoEvidence account.

SIGNUP

Already Have an Account?

Loading...
Visit our Evidence-Based Covid-19 Website and Stay Up to Date with the latest Research.
Ace Report Cover

Comparable Efficacy of Hyaluronic Acid and Biologic Injections for Early Knee Osteoarthritis

Share
Reprints
Cite This
About
+ Favorites
Share
Reprints
Cite This
About
+ Favorites
Ace Report Cover
March 2025

Comparable Efficacy of Hyaluronic Acid and Biologic Injections for Early Knee Osteoarthritis

Vol: 307| Issue: 3| Number:2| ISSN#: 2564-2537
Study Type:Therapy
OE Level Evidence:1
Journal Level of Evidence:1

Similar efficacy of intra-articular hyaluronic acid injections and other biologically active injections in patients with early stages knee osteoarthritis: a level I meta-analysis.

Arch Orthop Trauma Surg . 2024 Dec 18;145(1):68.

Contributing Authors:
F Migliorini L Schafer M Pilone A Bell F Simeone N Maffulli

Did you know you're eligible to earn 0.5 CME credits for reading this report? Click Here

Synopsis

Four randomized controlled trials (RCTs) including 390 patients with early-stage knee osteoarthritis (KL I-II) were included in this systematic review and meta-analysis comparing intra-articular hyaluronic acid (HA) injections with other biologically active injections such as platelet-rich plasma (PRP) and corticosteroids (CSs). Pooled outcomes of interest included the visual analogue scale (VAS),...

CME Image

Did you know that you’re eligible to earn 0.5 CME credits for reading this report!

LEARN MORE

Join the Conversation

Please Login or Join to leave comments.

Learn about our AI Driven
High Impact Search Feature

High Impact Icon

Our AI driven High Impact metric calculates the impact an article will have by considering both the publishing journal and the content of the article itself. Built using the latest advances in natural language processing, OE High Impact predicts an article’s future number of citations better than impact factor alone.

Continue